Skip to search formSkip to main contentSkip to account menu

Cardioxane

Known as: Cardioxan 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Dexrazoxane

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Механізм розвитку кардіотоксичності за умов використання антрациклінових антибіотиків та аналіз механізмів кардіопротекторної дії лікарських засобів та сполук різних хімічних груп
Aim. Research of the main directions of the search of cytoprotectors under anthracycline antibiotics intoxication conditions for… 
2004
2004
[Cardioxan: prevention of anthracycline-related cardiotoxicity].
2004
2004
[Cardioxan: prevention of anthracycline-related cardiotoxicity].
2002
2002
[Cardioxan--a drug of prevention of anthracycline-related cardiotoxicity in pediatric oncology].
2002
2002
[Cardioxan--a drug of prevention of anthracycline-related cardiotoxicity in pediatric oncology].
1996
1996
[Cardioxan as a cardioprotector in antineoplastic chemotherapy].
1996
1996
Cardioxan as a cardioprotector in antineoplastic chemotherapy
1994
1994
[The use of Cardioxan as a cardioprotective agent during antitumor chemotherapy].
1993
1993
[Prevention of cardiotoxicity of doxorubicin (Adriamycin) using cardioxane (ICRF-187, dexrazoxane) in the combination chemotherapy of disseminated breast cancer].
: Clinical, ultrasound and ECG studies of the left ventricle ejection fraction (LVEF) carried out in 25 patients with extensive… 
1993
1993
[Prevention of cardiotoxicity of doxorubicin (Adriamycin) using cardioxane (ICRF-187, dexrazoxane) in the combination chemotherapy of disseminated breast cancer].
Clinical, ultrasound and ECG studies of the left ventricle ejection fraction (LVEF) carried out in 25 patients with extensive…